General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Vaccines and Diagnostics

The Novartis Vaccines and Diagnostics Division provides more than 20 vaccines to prevent viral and bacterial diseases, as well as sophisticated instruments, assays and software to protect the blood supply from infectious diseases such as HIV and Hepatitis.

The division consists of two businesses - Novartis Vaccines and Novartis Diagnostics.


Novartis Vaccines

Novartis Vaccines is dedicated to delivering on the promise of prevention through the research, development and production of innovative, safe and effective vaccines. At the heart of everything we do is our commitment to preventing the spread of life-threatening diseases, protecting vulnerable populations, and keeping healthy people healthy.

By focusing on disease prevention, Novartis Vaccines plays a key role in the company's core mission: keeping people healthy, alleviating suffering and enhancing quality of life.

The current vaccine portfolio includes vaccines to prevent:

  • Influenza
  • Meningitis
  • Rabies
  • Japanese encephalitis
  • Tick-borne encephalitis
  • Haemophilus Influenzae type B (Hib)
  • Polio
  • Diphtheria
  • Tetanus
  • Pertussis (whooping cough)

Novartis Diagnostics

Novartis Diagnostics products are used to screen millions of blood donations around the world each year for pathogens such as HIV (the AIDS virus), hepatitis B and hepatitis C and West Nile virus before they are used in transfusions or other medical therapies.

Building on its strong presence in transfusion medicine, Novartis Diagnostics is also creating innovative preventive screening solutions to detect, prevent and predict disease and to improve medical outcomes.